stockrowDianthus Therapeutics, Inc. (DNTH) vs Erasca, Inc. (ERAS)
- Dianthus Therapeutics, Inc. DNTH 86.43 +4.12%
- Erasca, Inc. ERAS 14.34 +8.06%
Dianthus Therapeutics, Inc. and Erasca, Inc. are both Biotechnology companies. Dianthus Therapeutics, Inc. and Erasca, Inc. are of similar size ($4.6B and $4.6B). Erasca, Inc. has the higher net margin (0.00% vs −7,436.5%) and the lower return on invested capital (−203.1% vs −36.6%). Across the 13 metrics below, Dianthus Therapeutics, Inc. leads on 8 and Erasca, Inc. on 5.
Valuation
Profitability
| Metric | DNTH | ERAS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 0.00% | 68.51% |
| Operating margin | (8,683.89%) | 0.00% | 0.00% |
| Net margin | (7,436.50%) | 0.00% | 0.00% |
| Free cash flow margin | (6,469.87%) | 0.00% | 0.00% |
| Return on equity | (22.61%) | (78.25%) | (51.96%) |
| Return on assets | (21.81%) | (65.25%) | (46.06%) |
| Return on invested capital | (36.55%) | (203.13%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack